PRODUCTS

Restylane logo
Macrolane logo
Deflux logo
Durolane logo
Solesta logo

Q-MED AB
SEMINARIEGATAN 21
752 28 UPPSALA, SWEDEN
Phone: +46-(0)18-474 90 00
Fax: +46-(0)18-474 90 01
E-mail: info@q-med.com

Contact information

WELCOME TO Q-MED

Q-Med is a rapidly growing and profitable biotechnology/medical device company that primarily develops, manufactures, markets and sells medical implants. Most of the products are based on the company's patented technology, NASHA™, for the production of stabilized non-animal hyaluronic acid.

The company today has more than 700 co-workers in 20 countries, with approximately 500 at the company's head office and production facility in Uppsala.

Q-Med had sales of 1,318 MSEK during 2007. Q-Med AB is listed in the Mid Cap segment of the OMX Nordic Stock Exchange in Stockholm.


Capital Markets Day May 8th, 2008

Q-Med invites analysts, investors and media to Capital Markets Day on May 8th.

Program »

Annual General Meeting 2008

The Annual General Meeting of Q-Med AB was held on Tuesday April 29, 2008 on Q-Med’s premises at Fyrisvallsgatan 5, Uppsala.

THE Q-MED SHARE

QMED 09/05/2008 18:00:43 -0.23% -0.10 sek, Vol: 598 860
Last: 42.70 sek High: 43.60 sek Low: 42.70 sek
The Q-Med share

Press releases

[ 29/04/2008 12:35:00 ] Interim Report January - March 2008

Press releases

Reports

[ 2008-04-07 14:25 ] Annual Report 2007

Financial reports

Sales development